We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.9B
1-Year Est. Return 39.77%
This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+39.77%
3 Year Est. Return
+108.07%
5 Year Est. Return
+139.85%
10 Year Est. Return
+551.6%
AUM
$431M
AUM Growth
-$72.2M
Cap. Flow
-$3.61M
Cap. Flow %
-0.84%
Top 10 Hldgs %
21.82%
Holding
463
New
22
Increased
32
Reduced
Closed
43

Top Buys

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$652K
2
SLB icon
SLB Ltd
SLB
+$560K
3
CVS icon
CVS Health
CVS
+$478K
4
MPC icon
Marathon Petroleum
MPC
+$466K
5
PNR icon
Pentair
PNR
+$462K

Top Sells

Rank Stock Value
1
PX
Praxair Inc
PX
+$2.57M
2
AET
Aetna Inc
AET
+$1.55M
3
CI icon
Cigna
CI
+$1.14M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$469K
5
ANDV
Andeavor
ANDV
+$430K

Sector Composition

Rank Sector Weight
1 Technology 19.11%
2 Healthcare 16.34%
3 Financials 16.19%
4 Consumer Discretionary 10.11%
5 Communication Services 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPC icon
101
Marathon Petroleum
MPC
$119B
$1.1M 0.26%
18,651
+6,825
+58% +$466K
TFC icon
102
Truist Financial
TFC
$59.3B
$1.08M 0.25%
25,054
PGR icon
103
Progressive
PGR
$125B
$1.07M 0.25%
17,816
SCHW
104
Charles Schwab
SCHW
$181B
$1.07M 0.25%
25,758
ROP icon
105
Roper Technologies
ROP
$37B
$1.05M 0.24%
3,929
ICE icon
106
Intercontinental Exchange
ICE
$86.3B
$1.05M 0.24%
13,888
IFF icon
107
International Flavors & Fragrances
IFF
$21.8B
$1.03M 0.24%
7,648
INTU icon
108
Intuit
INTU
$84.4B
$1.02M 0.24%
5,164
CL icon
109
Colgate-Palmolive
CL
$69.6B
$1.01M 0.23%
16,977
KMI icon
110
Kinder Morgan
KMI
$69.7B
$1M 0.23%
65,181
BSX icon
111
Boston Scientific
BSX
$62.9B
$996K 0.23%
28,192
MET icon
112
MetLife
MET
$62.1B
$986K 0.23%
24,023
MS icon
113
Morgan Stanley
MS
$320B
$986K 0.23%
24,871
VRTX icon
114
Vertex Pharmaceuticals
VRTX
$130B
$975K 0.23%
5,884
ILMN icon
115
Illumina
ILMN
$36.7B
$974K 0.23%
3,340
TRV icon
116
Travelers Companies
TRV
$78.7B
$964K 0.22%
8,053
TJX icon
117
TJX Companies
TJX
$138B
$930K 0.22%
20,786
MAR icon
118
Marriott International
MAR
$87.4B
$929K 0.22%
8,558
PLD icon
119
Prologis
PLD
$129B
$921K 0.21%
15,692
+2,630
+20% +$170K
VLO icon
120
Valero Energy
VLO
$118B
$908K 0.21%
12,110
+2,080
+21% +$183K
BALL icon
121
Ball Corp
BALL
$16.1B
$904K 0.21%
19,651
ESRX
122
DELISTED
Express Scripts Holding Company
ESRX
$904K 0.21%
9,787
EMR icon
123
Emerson Electric
EMR
$82.1B
$901K 0.21%
15,073
BAX icon
124
Baxter International
BAX
$12B
$884K 0.2%
13,432
DOV icon
125
Dover
DOV
$25.5B
$875K 0.2%
12,326

Similar funds

Everence Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Everence Capital Management held 463 positions worth $431M, down 14% from $504M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Everence Capital Management's Q4 2018 filing shows 22 new, 32 increased and 43 closed positions. Its largest new stake was Pentair: 11,430 shares worth $432K. The largest sale was Praxair Inc, an estimated $2.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Everence Capital Management's largest Q4 2018 buy was Pentair: 11,430 shares worth $432K.
  • Everence Capital Management added most to Phillips 66 in Q4 2018, an estimated $652K increase.
  • Everence Capital Management fully exited Praxair Inc in Q4 2018, selling an estimated $2.57M.
  • Everence Capital Management's ten largest holdings make up 22% of its $431M portfolio in Q4 2018.
  • Everence Capital Management opened 22 new positions and closed 43 in Q4 2018.
  • Everence Capital Management's portfolio value fell 14% quarter-over-quarter to $431M.

Based on Everence Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.